Anthony Daniels, M.D., is assistant professor of ophthalmology and visual sciences, cancer biology, and radiation oncology and director of ocular oncology at the Vanderbilt Eye Institute. His lab at the Vanderbilt-Ingram Cancer Center is focused on drug discovery for various eye cancers, including uveal melanoma and retinoblastoma, in order to improve efficacy and minimize toxicities associated with treatment.
